Kinesiophobia Scale for the Upper Extremity

November 18, 2025 updated by: Emre Şenocak

Development of the Multidimensional Kinesiophobia Scale for the Upper Extremity: A Scale Development Study

Questionnaires/scales used to evaluate kinesiophobia in the literature are limited and are not specific to the upper extremity in existing scales. For this reason, the primary purpose and subject of the study is to develop a multi-factor kinesiophobia scale specific to shoulder problems.

The study is an observational research. Participants will be interviewed twice in total. All primary and secondary outcomes will be assessed at the first meeting. The second come will be performed within 5-7 days after the first assessment. In the second come, only the new kinesiophobia scale that is intended to be developed will be applied.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Turkey (Türkiye)
      • Istanbul, Turkey (Türkiye), 34104
        • Not yet recruiting
        • Clinic of İstanbul Hand-Microsurgery Rehabilitation
        • Contact:
        • Contact:
      • Istanbul, Turkey (Türkiye)
        • Recruiting
        • Clinic of İstanbul Hand-Microsurgery Rehabilitation
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Traumatological, orthopedic and rheumatological pathologies that cause fear of movement in the upper extremity

Description

Inclusion Criteria:

  • Tampa Kinesiophobia Score >37 points
  • Presence of traumatological, orthopedic and rheumatological pathology in the upper extremity
  • Mini-Mental State Examination score >24 points

Exclusion Criteria:

  • Malignancy,
  • Psychiatric drug use,
  • Use of painkillers during evaluation periods,
  • Those who received physiotherapy before the study (last 6 months),
  • Those whose education level is below secondary school level,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Observational Group
All of the outcomes will be applied to patients who come to the outpatient clinic due to shoulder problems. Then, 1 week later, participants will be recalled to apply the multidimensional kinesiophobia scale a second time.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Multidimensional Kinesiophobia Scale (To be developed)
Time Frame: Baseline of the study
It is desired to be developed to evaluate the fear of movement that occurs due to upper extremity injuries.
Baseline of the study
Multidimensional Kinesiophobia Scale (To be developed)
Time Frame: 5-7 days after baseline assessment
It is desired to be developed to evaluate the fear of movement that occurs due to upper extremity injuries.
5-7 days after baseline assessment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale
Time Frame: Baseline of the study
Assesses pain severity. It scores between 0-10 points. A high score indicates high pain intensity.
Baseline of the study
Tampa Kinesiophobia Scale
Time Frame: Baseline of the study
It consists of 17 items. Assesses the fear of movement. Total score is 68 points. A high score indicates high fear.
Baseline of the study
Demographic Data Form
Time Frame: Baseline of the study
This form was created by researchers and it consist of personal informations such as gender, marital status, education, age, body mass index, dominant and affected extremity, name of pathology,
Baseline of the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Emre Şenocak

Investigators

  • Study Chair: Abdurrahman Tanhan, PhD, Bitlis Eren University
  • Study Chair: Zeynep Hoşbay, Associate Professor, Biruni University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 22, 2024

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

June 27, 2024

First Submitted That Met QC Criteria

June 27, 2024

First Posted (Actual)

July 3, 2024

Study Record Updates

Last Update Posted (Actual)

November 19, 2025

Last Update Submitted That Met QC Criteria

November 18, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024/74

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Injuries

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe